% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{HoangGia:907384,
author = {Hoang Gia, Linh and Goßen, Jonas and Capelli, Riccardo and
Nguyen, Toan T. and Sun, Zhaoxi and Zuo, Ke and Schulz,
Jörg B. and Rossetti, Giulia and Carloni, Paolo},
title = {{M}ultiple {P}oses and {T}hermodynamics of {L}igands
{T}argeting {P}rotein {S}urfaces: {T}he {C}ase of
{F}urosemide {B}inding to mito{NEET} in {A}queous
{S}olution},
journal = {Frontiers in cell and developmental biology},
volume = {10},
issn = {2296-634X},
address = {Lausanne},
publisher = {Frontiers Media},
reportid = {FZJ-2022-02005},
pages = {886568},
year = {2022},
abstract = {Human NEET proteins, such as NAF-1 and mitoNEET, are
homodimeric, redox iron-sulfur proteins characterized by
triple cysteine and one histidine-coordinated [2Fe-2S]
cluster. They exist in an oxidized and reduced state.
Abnormal release of the cluster is implicated in a variety
of diseases, including cancer and neurodegeneration. The
computer-aided and structure-based design of ligands
affecting cluster release is of paramount importance from a
pharmaceutical perspective. Unfortunately, experimental
structural information so far is limited to only one
ligand/protein complex. This is the X-ray structure of
furosemide bound to oxidized mitoNEET. Here we employ an
enhanced sampling approach, Localized Volume-based
Metadynamics, developed by some of us, to identify binding
poses of furosemide to human mitoNEET protein in solution.
The binding modes show a high variability within the same
shallow binding pocket on the protein surface identified in
the X-ray structure. Among the different binding
conformations, one of them is in agreement with the crystal
structure’s one. This conformation might have been
overstabilized in the latter because of the presence of
crystal packing interactions, absent in solution. The
calculated binding affinity is compatible with experimental
data. Our protocol can be used in a straightforward manner
in drug design campaigns targeting this pharmaceutically
important family of proteins.},
cin = {IAS-5 / INM-9 / JSC},
ddc = {570},
cid = {I:(DE-Juel1)IAS-5-20120330 / I:(DE-Juel1)INM-9-20140121 /
I:(DE-Juel1)JSC-20090406},
pnm = {5252 - Brain Dysfunction and Plasticity (POF4-525) / 5251 -
Multilevel Brain Organization and Variability (POF4-525) /
5111 - Domain-Specific Simulation Data Life Cycle Labs
(SDLs) and Research Groups (POF4-511) / DFG project
291198853 - FOR 2518: Funktionale Dynamik von Ionenkanälen
und Transportern - DynIon -},
pid = {G:(DE-HGF)POF4-5252 / G:(DE-HGF)POF4-5251 /
G:(DE-HGF)POF4-5111 / G:(GEPRIS)291198853},
typ = {PUB:(DE-HGF)16},
UT = {WOS:000795047600001},
doi = {10.3389/fcell.2022.886568},
url = {https://juser.fz-juelich.de/record/907384},
}